DR. MAYEZ A EL-HARAKE MD NPI 1578550679

NPI Details

DR. Mayez A El-harake, MD is a medical oncology internal medicine in Beckley, WV with 45 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Mayez A El-harake, MD NPI is 1578550679. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

275 DRY HILL RD
BECKLEY, WV
ZIP 25801-605
Phone: (304) 253-6060
Fax: (304) 929-2248

The NPI 1578550679 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml (HCPCS:Q9965)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Injection, cisplatin, powder or solution, 10 mg (HCPCS:J9060)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Ct scan of chest with contrast (HCPCS:71260)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Injection, doxorubicin hydrochloride, 10 mg (HCPCS:J9000)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Screening mammography (HCPCS:77067)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Ct scan of chest without contrast (HCPCS:71250)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Unclassified drugs (HCPCS:J3490)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Vincristine sulfate, 1 mg (HCPCS:J9370)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
• Complete x-ray of body bones (HCPCS:77075)
• Blood creatinine level (HCPCS:82565)
• X-ray of chest, 2 views (HCPCS:71046)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection of drug or substance into vein (HCPCS:96374)
• Diagnostic mammography of both breasts (HCPCS:77066)
• Ct scan of head or brain before and after contrast (HCPCS:70470)
• Ct scan of soft tissue of neck with contrast (HCPCS:70491)

The enumeration date for this NPI number is 10/4/2005 and was last updated on 7/8/2007.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.